Assaf Segal, based in Israel, is currently a Chief Executive Officer at Clal Biotechnology Industries, bringing experience from previous roles at Clal Biotechnology Industries, Anatomy Medical Technologies, eXIthera Pharmaceuticals LLC and Elicio Therapeutics. Assaf Segal holds a 1986 - 1999 MBA in Finance & Information Systems @ The Hebrew University. With a robust skill set that includes Corporate Finance, Valuation, Private Equity, Capital Markets, Venture Capital and more, Assaf Segal contributes valuable insights to the industry. Assaf Segal has 1 email on RocketReach.